Dr. Tyson Scott Sessions is a Meridian, Idaho based physiatrist who is specialized in Pain Management (PM&R). Active license number of Dr. Tyson Scott Sessions as Pain Management (PM&R) is O-1928 in Idaho.
Dr. Tyson Scott Sessions provides a high level of care, either as a primary physician or consultant, for patients experiencing problems with acute, chronic or cancer pain in both hospital and ambulatory settings. Patient care needs may also be coordinated with other specialists.
Complete Profile:
Dr. Tyson Scott Sessions speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Pain Management (PM&R)
Credentials:
DO
Gender:
Male
Practice Address:
3551 E Overland Rd, Meridian, Idaho, 83642-6757
Phone:
208-884-1333
Fax:
208-489-4015
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1447710025
NPI Enumeration Date:
21 Mar, 2019
NPI Last Update On:
25 Sep, 2024
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Tyson Scott Sessions are as mentioned below.
License Number
Specialization
State
Status
O-1928
Pain Management
Idaho
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
2001 W 86th St, 3 North Indianapolis, Indiana
Zip:
46260-1991
Phone Number:
317-338-6089
Fax Number:
317-338-2851
Patients can reach Dr. Tyson Scott Sessions at 3551 E Overland Rd, Meridian, Idaho or can call to book an appointment on 208-884-1333. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.